TG
RDY icon

TCW Group’s Dr. Reddy's Laboratories RDY Stock Holding History

TCW Group’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-206,500
Closed -$1.56M – 337
2018
Q4 		$1.56M Sell
206,500
-86,000
-29% -$605K 0.02% 232
2018
Q3 		$2.02M Buy
292,500
+2,000
+0.7% +$13.4K 0.02% 228
2018
Q2 		$1.87M Buy
+290,500
New +$1.83M 0.02% 227

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

TCW Group's RDY Position: Q1 2019 in Review

TCW Group sold out of Dr. Reddy's Laboratories (RDY) in Q1 2019, closing a stake of 206,500 shares — an estimated $1.56M sold.

TCW Group first reported a position in RDY in Q2 2018 and held it in 3 quarters. The position peaked at $2.02M in Q3 2018. 143 funds tracked by Wall St. Rank hold RDY as of Q1 2019.

  • TCW Group reported no remaining Dr. Reddy's Laboratories position as of Q1 2019 after selling out during the quarter.
  • TCW Group sold 206,500 Dr. Reddy's Laboratories shares in Q1 2019, an estimated $1.56M.
  • TCW Group first reported a position in Dr. Reddy's Laboratories in Q2 2018 and held it in 3 quarters.
  • TCW Group's Dr. Reddy's Laboratories position peaked at $2.02M in Q3 2018.
  • 143 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2019.

Based on TCW Group's 13F filing for Q1 2019, filed 13 May 2019.